Definitive Contract HT942525CE021
- Not listed
- The Department of the Air Force Materiel Command Research Laboratory awarded a $74,437 firm fixed price purchase order to Safetraces Inc. under the Small Business Innovation Research Program Phase I solicitation. This contract will support the development of safe aerosol simulants to verify removal of toxic particles in United States Air Force facilities, with work to be completed by August 3, 2023 at Safetraces's facility in Pleasanton, California. As a total small business set-aside, this SBIR...
- The Defense Health Agency awarded a $1.3 million Phase II Small Business Innovation Research (SBIR) contract to Tao Treasures, LLC, doing business as Nanobiofab, for development of TRISENSE, an artificially intelligent volatile organic compound sensing system designed for culture-free infection diagnosis in biofluids. This total small business set-aside contract, awarded on September 15, 2025, represents a continuation of the SBIR program's support for innovative medical technologies and is...
- The Defense Health Agency awarded a $1.3 million Small Business Innovation Research (SBIR) Phase II contract to Tao Treasures, LLC, doing business as Nanobiofab, on September 5, 2025. The contract, designated as a Total Small Business set-aside, supports development of Rapid-INOSE, a next-generation intelligent diagnostic platform designed to enable precision infection management through broad-spectrum volatile organic compound (VOC) sensing and artificial intelligence. The work is scheduled for...
- The Department of the Air Force Materiel Command Research Laboratory awarded a $749,453 firm fixed price contract to Safetraces Inc. for the purpose of Increasing Air Force Personnel Health and Mission Effectiveness through Air Quality Testing and Aerosol Simulants. The contract is a Small Business Technology Transfer Phase II award with a period of performance from July 22, 2022 through October 23, 2023 to be performed in Pleasanton, California. Safetraces Inc. will serve as the prime...
- This is a Small Business Innovation Research (SBIR) Phase I research and development contract awarded by the Defense Health Agency (DHA) to SPZ Technologie LLC, a for-profit limited liability company. The $162,326.22 firm fixed-price contract is for the development of a "Novel Cell-Based Biosensor for Rapid Field Water Toxicity Detection" under Topic DHA191-006. The contract was set aside for small businesses and has a completion date of February 7, 2020. As an SBIR Phase I award, this...
- The U.S. Air Force Research Laboratory (AFRL) awarded a $1.25 million SBIR Phase II contract to Dxlab Inc., a small business based in Somerville, Massachusetts, on June 7, 2024. Under this firm fixed-price purchase order, Dxlab will develop a portable and rugged infection diagnostic platform designed to deliver rapid, clinically actionable pathogen detection capabilities at deployed military locations and treatment facilities. The contract is designated as a Total Small Business set aside and...
- The Defense Health Agency (DHA) awarded a $1.3 million firm fixed-price contract to Advanced Cooling Technologies Inc. (ACT), a small business based in Lancaster, Pennsylvania, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, designated as a Total Small Business set-aside, supports the development of a psoralen-UV-A irradiation-based high-throughput pathogen inactivation device. The award was issued on July 2, 2025, with an ultimate completion date of...
- The Defense Health Agency awarded a $1.95 million Phase II Small Business Innovation Research (SBIR) contract to Puriolabs, LLC on September 5, 2025, for continued development of the Puritall Sterilizer. Under this firm fixed-price definitive contract, the small business concern will execute research and development activities through January 4, 2028, at its facility in Carrollton, Texas. The contract carries a total small business set-aside designation, reserving the opportunity exclusively for...
- The Defense Health Agency awarded a $3.0 million Phase II Small Business Innovation Research (SBIR) contract to Technology Holding LLC, a small business based in Salt Lake City, Utah, for the development of a novel biologic countermeasure for acute radiation syndrome. This 23-month effort, which commenced on June 21, 2022, and concludes October 20, 2026, is structured as a firm fixed-price definitive contract under the SBIR program's Phase II action, which supports innovative research and...
- The Department of the Army Medical Command awarded a $1.1 million firm fixed price contract to SPZ Technologie LLC under the Small Business Innovation Research Program Phase II. The research contract is for the continued development of a human cell-based biosensor to address Topic DHA191-006 from the Military Operational Medicine Research Program solicitation. All work will be performed by SPZ Technologie in Los Angeles, California over a three-year period concluding in March 2024. The award was...
The Defense Health Agency awarded a $1.3 million Phase II Small Business Innovation Research (SBIR) contract to Safetraces, Inc. on September 15, 2025, for the development of field-deployable environmental biosensing technology to support military readiness through rapid pathogen intelligence. The contract, designated as a total small business set-aside with firm fixed pricing, is scheduled for completion by January 14, 2028, and will be performed at the awardee's facility in Pleasanton, California. This Phase II award represents a continuation of the company's SBIR program participation and builds upon earlier phase research to advance biosensing capabilities for defense applications. Safetraces, Inc. brings significant expertise to this engagement, having established a track record with the federal government since 2015 in developing advanced scientific and technological solutions for environmental assessment and safety testing. The company has previously secured multiple contracts focused on air quality assessment, aerosol technologies, and personnel health monitoring, demonstrating particular strength in innovative testing and detection systems for defense-related challenges. The current award reflects the Defense Health Agency's investment in novel sensing technologies that can enhance operational readiness by enabling rapid identification of pathogenic threats in military environments, positioning Safetraces' environmental biosensing innovations as a critical capability for force protection.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $636.1k | 9/5/25 |